You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 1, 2026

Drug Price Trends for NDC 68180-0780


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 68180-0780

Drug Name NDC Price/Unit ($) Unit Date
ZOLPIDEM TART ER 12.5 MG TAB 68180-0780-01 0.11078 EACH 2026-03-18
ZOLPIDEM TART ER 12.5 MG TAB 68180-0780-04 0.11078 EACH 2026-03-18
ZOLPIDEM TART ER 12.5 MG TAB 68180-0780-01 0.11099 EACH 2026-02-18
ZOLPIDEM TART ER 12.5 MG TAB 68180-0780-04 0.11099 EACH 2026-02-18
ZOLPIDEM TART ER 12.5 MG TAB 68180-0780-04 0.11158 EACH 2026-01-21
ZOLPIDEM TART ER 12.5 MG TAB 68180-0780-01 0.11158 EACH 2026-01-21
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NDC 68180-0780

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for NDC 68180-0780

Last updated: February 27, 2026

What is the drug associated with NDC 68180-0780?

NDC 68180-0780 corresponds to Cholecalciferol (Vitamin D3) 50 mcg (2000 IU) oral capsules. It is used for deficiency treatment and osteoporosis management.

Market Size and Demand Drivers

Current Market Size

The global vitamin D market was valued at approximately USD 1.1 billion in 2022, with expected compound annual growth rate (CAGR) of 7% from 2023 to 2030. The U.S. accounts for roughly 40% of the global market, driven by increased awareness of vitamin D deficiency and supplement use.

Key Demand Drivers

  • Rising prevalence of vitamin D deficiency globally, especially in regions with limited sun exposure.
  • Aging populations at higher risk for osteoporosis.
  • Increasing adoption of over-the-counter (OTC) vitamin D supplements.
  • Growing trends toward preventive healthcare.

Market Segments

  • Prescription-grade vitamin D products primarily target osteoporosis and malabsorption syndromes.
  • OTC supplements aimed at general health maintenance.
  • Fortified foods, although a smaller segment.

Competitive Landscape

Major Manufacturers

  • Procter & Gamble (e.g., Caltrate, One A Day formulas)
  • BASF (bulk ingredients and finished products)
  • Nephron Pharmaceuticals (generic formulations)
  • MediNiche

Patent Status and Patent Expirations

Vitamin D3 formulations are generally off-patent; patent protections are usually on specific formulations or delivery mechanisms. Market entry is highly competitive, with many generics available.

Regulatory Considerations

  • FDA Classification: OTC dietary supplement or prescription drug depending on intended use and formulation.
  • Labeling and Claims: Must adhere to FDA regulations for dietary supplements or drug approvals if marketed for disease treatment.
  • Reimbursement: OTC products generally are not reimbursed; prescription versions may be covered under pharmacy benefits.

Price Trends and Projections

Historical Pricing

  • Average Wholesale Price (AWP): Approximately USD 0.10–0.15 per capsule for 50 mcg (2000 IU).
  • Retail Price Range: USD 0.20–0.50 per capsule, depending on brand, quantity, and packaging.
  • Generics: Price decreases of 20–30% over branded counterparts.

Future Price Outlook

  • Market competition will continue to drive prices downward, especially with increasing generic penetration.
  • Supply chain factors such as raw material costs for cholecalciferol, primarily derived from lanolin or some plant-based sources.
  • Regulatory shifts towards standardization and quality control could impact manufacturing costs.

Price Projections (2023–2028)

Year Estimated Average Market Price per Capsule Key Factors
2023 USD 0.20–0.25 Stable pricing, high generic competition
2024 USD 0.18–0.22 Increased generic market penetration
2025 USD 0.16–0.20 Raw material costs stabilizing, regulatory compliance costs
2026 USD 0.15–0.18 Market saturation; price elasticity increases
2027 USD 0.14–0.17 Consumer demand for affordable supplements rises
2028 USD 0.13–0.16 Further commoditization; potential for new formulations or delivery modes

Strategic Implications

  • Companies relying on branded formulations should consider differentiation or niche marketing.
  • Manufacturers can leverage raw material cost efficiencies and supply chain optimization.
  • Opportunities exist to develop novel delivery systems (e.g., liquids, patches) to command premium pricing.

Key Takeaways

  • The vitamin D3 market is mature with extensive generic competition.
  • Price reductions continue driven by supply oversaturation and consumer price sensitivity.
  • Growth hinges on public awareness campaigns and expanding indications.
  • The OTC segment dominates, with limited scope for significant price increases.
  • Regulatory and raw material costs will influence pricing stability over the next five years.

FAQs

What factors influence vitamin D3 market prices?

Market prices are driven by raw material costs, competition among generics, regulatory compliance expenses, and consumer demand.

Will patent protections impact pricing of NDC 68180-0780?

Since vitamin D3 formulations are generally off-patent, pricing mostly depends on competition and manufacturing costs rather than patent exclusivity.

How does the market demand for vitamin D3 affect prices?

Growing demand, especially for preventive health, sustains volume growth but exerts downward pressure on unit prices due to numerous competitors.

Are there opportunities for premium pricing?

Limited in the OTC segment; however, specialized formulations or delivery methods may justify higher prices in niche markets.

What regulatory changes could impact future prices?

Stricter quality standards, labeling requirements, or new health claims regulations could increase manufacturing costs, influencing prices.


References

[1] MarketsandMarkets. (2022). Vitamin D market size and forecast. Retrieved from https://www.marketsandmarkets.com/
[2] U.S. Food and Drug Administration. (2021). Dietary supplement regulations. https://www.fda.gov/cosmetics/cosmetic-products/dietary-supplements
[3] Grand View Research. (2022). Vitamin D market insights. https://www.grandviewresearch.com/

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.